18F-fluoride PET for monitoring therapeutic response in Paget's disease of bone

Journal of Nuclear Medicine

Volumn 46, Issue 10, 2005, Pages 1650-1658

  Installé, Johanne ^a   Nzeusseu, Adrien ^a   Bol, Anne ^a   Depresseux, Geneviève ^a   Devogelaer, Jean Pierre ^a   Lonneux, Max ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

18F fluoride; Kinetic modeling; Paget's disease; PET; Therapeut b ic response

Indexed keywords

BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; FLUORINE 18; BONE DENSITY CONSERVATION AGENT; DIAGNOSTIC AGENT; FLUORIDE; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; BONE TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; PAGET BONE DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; FEASIBILITY STUDY; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEASIBILITY STUDIES; FEMALE; FLUORIDES; FLUORINE RADIOISOTOPES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; OSTEITIS DEFORMANS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33644674544     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hawkins RA, Choi Y, Huang SC, et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med. 1992;33:633-642.
2. 18F]fluoride ion PET: correlation with bone histomorphometry. J Nucl Med. 2001;42:1091-1100.
3. Schiepers C, Nuyts J, Bormans G, et al. Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med. 1997;38:1970-1976.
4. 18F- fluoride positron emission tomography. J Bone Miner Res. 2002;17:854-859.
5. 18E-fluoride positron emission tomography. J Bone Miner Res. 2003;18:2215-2222.
6. Devogelaer JP. Modern therapy for Paget's disease of bone: focus on bisphosphonates. Treat Endocrinol. 2002;1:241-257.
7. Alvarez L, Guanabens N, Peris P, et al. Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease. Bone. 2001;29:447-452.
8. Cook GJ, Lodge MA, Marsden PK, Dynes A, Fogelman I. Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions. Eur J Nucl Med. 1999;26:1424-1429.
9. 18F-FDG PET. J Nucl Med. 2002;43:1304-1309.
10. 18F-fluoride PET scans. J Nucl Med. 2004;45:1493-1500.
11. Wienhard K, Dahlbom M, Eriksson L, et al. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr. 1994;18:110-118.
12. Maldague B, Malghem J. Medical imaging of Paget's disease [in French]. Rev Prat. 1989;39:1113-1124.
13. Ryan PJ, Gibson T, Fogelman I. Bone scintigraphy following intravenous pamidronate for Paget's disease of bone. J Nucl Med. 1992;33:1589-1593.
14. 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease. Metab Bone Dis Relat Res. 1984;5:167-170.
15. Pecherstorfer M, Schilling T, Janisch S, et al. Effect of clodronate treatment on bone scintigraphy in metastatic breast cancer. J Nucl Med. 1993;34:1039-1044.
16. Sandler ED, Parisi MT, Hattner RS. Duration of etidronate effect demonstrated by serial bone scintigraphy. J Nucl Med. 1991;32:1782-1784.
17. Hommeyer SH, Vamey DM, Eary JF. Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy. J Nucl Med. 1992;33:748-750.
18. Patel U, Gallacher SJ, Boyle IT, McKillop JH. Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment. Nucl Med Commun. 1990;11:747-760.
19. Vellenga CJ, Pauwels EK, Bijvoet OL. Comparison between visual assessment and quantitative measurement of radioactivity on the bone scintigram in Paget's disease of bone. Eur J Nucl Med. 1984;9:533-537.
20. 18F]fluoride ion and PET. J Comput Assist Tomogr. 1993;17:34-41.
21. 99mTc-methylene diphosphonate. Semin Nucl Med. 2001;31:28-49.
22. 18F in rabbit bone. Clin Phys Physiol Meas. 1986;7:333-343.
23. 18F-fluoride positron emission tomography in postmenopausal women. J Bone Miner Res. 2000;15:763-769.